Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCWC.L Share News (CWC)

  • There is currently no data for CWC

Tuesday broker round-up UPDATE

Tue, 17th Dec 2013 08:14
Advanced Medical Solutions: Panmure Gordon downgrades from buy to hold with a target price of 102p.Antofagasta: Canaccord Genuity cuts target price from 1110p to 1035p, while staying with its buy recommendation.ASOS: Panmure Gordon increases target price from 5950p to 6126p, while downgrading from buy to hold.AstraZeneca: Deutsche Bank raises target price from 3425p to 3600p maintaining a hold recommendation.blur Group: Panmure Gordon ups target price from 677p to 690p and retains a buy recommendation.British American Tabacco: UBS reduces target price from 3850p to 3715p, while its buy recommendation remains unchanged.BTG: Deutsche Bank ups target price from 565p to 610p and reiterates its buy recommendation.Cable & Wireless Communications: Barclays shifts target price from 40p to 43p and retains an equal-weight rating.Daily Mail & General Trust: Westhouse Securities raises target price from 744p to 864p and maintains a neutral rating.Daisy Group: Barclays moves target price from 115p to 130p, but downgrades to underweight.Dixons Retail: Cantor Fitzgerald ups target price from 50p to 60p keeping a buy recommendation. Investec shifts target price from 60p to 62p retaining its buy recommendation.Europa Oil & Gas: Northland lowers target price from 14.3p to 10.1p leaving its buy recommendation unchanged.Experian: Jefferies reduces target price from 1200p to 1090p and keeps a hold recommendation.First Derivates: Panmure Gordon raises target price from 1191p to 1458p and keeps a buy recommendation.First Group: Goldman Sachs shifts target price from 135p to 140p and retains a buy recommendation.GlaxoSmithKline: Deutsche Bank reduces target price from 1800p to 1700p while downgrading to hold.Go-Ahead Group: Goldman Sachs increases target price from 1580p to 2100p and upgrades to a strong buy recommendation.Imagination Technologies: Barclays cuts target price from 250p to 185p and reiterates an equal-weight rating.Informa: Canaccord Genuity cuts target price from 600p to 568p downgrading from buy to hold.Inmarsat: Barclays takes target price from 705p to 740p and keeps an equal-weight rating.KCOM Group: Barclays moves target price from 100p to 115p retaining its overweight rating.Sepura: Westhouse Securities upgrades from add to buy with an unchanged target price of 160p.Stagecoach Group: Goldman Sachs downgrades to sell with a target price of 350p.Trinity Mirror: Panmure Gordon increases target price from 205p to 300p maintaining a buy recommendation.UBM: Deutsche Bank moves target price from 830p to 840p retaining a buy recommendation. Westhouse Securities reduces target price from 812p to 755p, while staying with its buy recommendation. Numis cuts target price from 732p to 710p and maintains a hold recommendation. Barclays reduces target price from 810p to 755p, while staying with its overweight rating.William Hill: Canaccord Genuity lowers target price from 425p to 408p leaving its hold recommendation unaltered.Wood Group: Canaccord Genuity cuts target price from 875p to 825p and reiterates a hold recommendation.Xcite Energy: Cantor Fitzgerald shapes target price from 168p to 167p leaving its buy recommendation unchanged.

Related News

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris
20 mins ago

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris

(Alliance News) - AstraZeneca PLC on Saturday announced new data on its kidney disease treatment Ultomiris.

IN BRIEF: British American Tobacco CEO buys GBP215,300 worth of shares
1 day ago

IN BRIEF: British American Tobacco CEO buys GBP215,300 worth of shares

British American Tobacco PLC - London-based cigarette and nicotine product maker - Chief Executive Tadeu Marroco and person closely associated Luciana...

PRESS: AstraZeneca warns it could delay Europe drug launches - FT
1 day ago

PRESS: AstraZeneca warns it could delay Europe drug launches - FT

(Alliance News) - AstraZeneca PLC could be forced to withhold new medicines from the UK and Europe unless governments pay more for innovative drugs, C...

CWC.L News

C&W Communications says Batelco Seychelles deal expires
2 Dec 2013

C&W Communications says Batelco Seychelles deal expires

LONDON, Dec 2 (Reuters) - Cable & Wireless Communications is considering options for its assets in the Seychelles after Bahrain Telecommunications Co...

Monday broker round-up UPDATE
2 Dec 2013

Monday broker round-up UPDATE

Aberdeen Asset Management: Credit Suisse raises target price from 465p to 515p and maintains a neutral rating. Admiral Group: Citi moves target price...

Ex-divs to take 11.6 points off FTSE 100 on Nov. 13
11 Nov 2013

Ex-divs to take 11.6 points off FTSE 100 on Nov. 13

LONDON, Nov 11 (Reuters) - The following FTSE 100 companies will go ex-dividend on Wednesday, after which investors will no longer qualify for the lat...

Monday broker round-up UPDATE
11 Nov 2013

Monday broker round-up UPDATE

Associated British Foods: Barclays downgrades to equal-weight with a target price of 2100p. Bovis Homes Group: Deutsche Bank moves target price from ...

Friday broker round-up UPDATE
8 Nov 2013

Friday broker round-up UPDATE

Abcam: Canaccord Genuity moves target price from 396p to 386p and keeps a sell recommendation. N+1 Singer shifts target price from 450p to 445p downgr...

FTSE 250 movers: Halfords charges higher on strong H1
7 Nov 2013

FTSE 250 movers: Halfords charges higher on strong H1

Car- and bike-parts retailer Halfords saw its shares rocket after delivering an impressive first half. The group posted profit before tax in the fir...

Cable & Wireless says smartphones help mobile return to growth
7 Nov 2013

Cable & Wireless says smartphones help mobile return to growth

* Mobile revenue in first half up 3 pct versus flat forecast * Shares rise to two-year high By Paul Sandle LONDON, Nov 7 (Reuters) - Britain's Cable &...